Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 1 5Phase 3 3Phase 2 2Phase 1/2 1

Status

Completed 6Terminated 5Recruiting 5Active not recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 2Plasma cell 1Other hematologic neoplasm 1NET 1Lymphoid 1Endocrine 1

Conditions

Neoplasms 281Carcinoma, Non-Small-Cell Lung 251Leukemia, Myeloid, Acute 189Breast Neoplasms 151Melanoma 150Neoplasm Metastasis 148Multiple Myeloma 127Recurrence 123Colorectal Neoplasms 119Lymphoma, Non-Hodgkin 113Lymphoma 112Leukemia, Lymphocytic, Chronic, B-Cell 107Pancreatic Neoplasms 99Ovarian Neoplasms 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 91Leukemia 85Prostatic Neoplasms 83Lung Neoplasms 81Lymphoma, Large B-Cell, Diffuse 77Squamous Cell Carcinoma of Head and Neck 76Glioblastoma 73Carcinoma, Renal Cell 72Myelodysplastic Syndromes 67Lymphoma, Follicular 65Brain Neoplasms 60Lymphoma, Mantle-Cell 55Sarcoma 53Stomach Neoplasms 52Head and Neck Neoplasms 52Triple Negative Breast Neoplasms 49

Interventions

idelalisib 1daratumumab 1alovudine 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Ga(III)-DOTATOC 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Terminated × Disease × Clear all
NCT03151057 2024-03-12

Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Terminated
16 enrolled 11 charts
LymphoidOther hematologic neoplasm

Disease, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT05641324 2024-02-12

A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)

Anaveon AG

Phase 1 Terminated
4 enrolled
Plasma cell

Disease, Hematologic Diseases, Multiple Myeloma, Neoplasms, Recurrence

NCT00633958 2021-10-20

FLT

Dana-Farber Cancer Institute

Phase 1 Terminated
2 enrolled
CNS

Disease, Central Nervous System Neoplasms

NCT02359500 2017-05-03

68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs)

Icahn School of Medicine at Mount Sinai

Phase 1 Terminated
71 enrolled
EndocrineNET

Carcinoid Tumor, Disease, Neuroendocrine Tumors

NCT01009866 2015-03-20

MR1-1

Duke University

Phase 1 Terminated
9 enrolled
CNS

Astrocytoma, Brain Neoplasms, Disease, Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡